An emerging trend of methamphetamine injection in Iran: A critical target for research on blood-borne infection diseases

Hepatitis Monthly

Volumn 13, Issue 2, 2013, Pages

  Mehrjerdi, Zahra Alam ^a   Noroozi, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood borne infections; Communicable diseases; Health; Iran; Methamphetamine

Indexed keywords

BUPRENORPHINE; METHAMPHETAMINE;

CONDOM; DRUG USE; EDITORIAL; HEALTH PROGRAM; HEPATITIS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; IRAN; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; SYRINGE NEEDLE;

EID: 84875303194     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.8154     Document Type: Editorial

References (24)

1. Mirahmadizadeh AR, Majdzadeh R, Mohammad K, Forouzanfar MH. Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iran Red Crescent Med J.2009;11(3):325-9.
2. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin- Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis.2010;14(1):e28-33.
3. Nokhodian Z, Meshkati M, Adibi P, Ataei B, Kassaian N, Yaran M, et al. Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors. Int J Prev Med.2012;3(Suppl 1):S131-8.
4. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex.2001;41(2):17-35.
5. Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse.1999;25(3):475-93.
6. Shoptaw S, Reback CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction.2007;102 Suppl 1:130-5.
7. Brewer DD, Golden MR, Handsfield HH. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sex Transm Dis.2006;33(4):250-5.
8. Semple SJ, Grant I, Patterson TL. Female methamphetamine users: social characteristics and sexual risk behavior. Women Health.2004;40(3):35-50.
9. Carey JW, Mejia R, Bingham T, Ciesielski C, Gelaude D, Herbst JH, et al. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behav.2009;13(6):1084-96.
10. Schwarcz S, Scheer S, McFarland W, Katz M, Valleroy L, Chen S, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health.2007;97(6):1067-75.
11. Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health.2006;83(3):497-505.
12. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav.2004;29(4):807-10.
13. Greenwell L, Brecht ML. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse.2003;29(1):75-104.
14. Vogt TM, Perz JF, Van Houten CK, Jr, Harrington R, Hansuld T, Bialek SR, et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction.2006;101(5):726-30.
15. Boddiger D. Metamphetamine use linked to rising HIV transmission. Lancet.2005;365(9466):1217-8.
16. World drug report.2012; p.
17. Zarghami M. Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Iran J Psy chiatr Behav Sci.2011;5(1):1-5.
18. Momtazi S, Rawson R. Substance abuse among Iranian high school students. Curr Opin Psychiatry.2010;23(3):221-6.
19. Mokhber N, Afshari R, Farhoodi F. Evaluation of the suicide risk factors among methadone maintenance treatment of opiate dependent individuals: A six month assessment. Open J Psychiatry. 2012;2(2):91-5.
20. Rafiey H, Narenjiha H, Shirinbayan P, Noori R, Javadipour M, Roshanpajouh M, et al. Needle and syringe sharing among Iranian drug injectors. Harm Reduct J.2009;6:21.
21. Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet.2006;368(9534):434-5.
22. Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J.2005;2:19.
23. Rose VJ, Raymond HF, Kellogg TA, McFarland W. Assessing the feasibility of harm reduction services for MSM: the late night breakfast buffet study. Harm Reduct J.2006;3:29.
24. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health.2004;81(1):14-9.